Esketamine

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift could revolutionize the cannabis industry. But what exactly is Schedule III? What other substances are produced and studied in this...

The Food and Drug Administration (FDA) issued an alert on the dangers of self-treating psychiatric disorders with unapproved compounded versions of ketamine and ketamine-based drugs whether modified or tailored for specific patient needs. In view of the anesthetic’s rising...

Ketamine-producer PharmaTher Holdings Ltd. (OTCQB: PHRRF) has successfully completed research evaluating its patented hydrogel-forming microneedle patch, PHARMAPATCH, to deliver ketamine and KETABET (ketamine and betaine anhydrous).  The combination aims to study the possibility of...

In February 2020, scientists in Brazil performed an open-label study on arketamine, a variant of ketamine. The pilot trial, conducted by the Federal University of Bahia, was performed on seven subjects suffering from treatment-resistant depression. It found evidence that arketamine might produce...

Johnson & Johnson (NYSE: JNJ) received encouraging news after a FDA panel decision went its way with respect to its treatment-resistant depression drug. Panel Finds Risk-Benefit Favorable A joint committee of the FDA's Psychopharmacologic Drug Advisory Committee and Drug Safety and Risk...